These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Autophagy inhibition attenuates hyperoxaluria-induced renal tubular oxidative injury and calcium oxalate crystal depositions in the rat kidney. Duan X, Kong Z, Mai X, Lan Y, Liu Y, Yang Z, Zhao Z, Deng T, Zeng T, Cai C, Li S, Zhong W, Wu W, Zeng G. Redox Biol; 2018 Jun; 16():414-425. PubMed ID: 29653411 [Abstract] [Full Text] [Related]
6. Generation and characterization of a novel rat model of primary hyperoxaluria type 1 with a nonsense mutation in alanine-glyoxylate aminotransferase gene. Li Y, Zheng R, Xu G, Huang Y, Li Y, Li D, Geng H. Am J Physiol Renal Physiol; 2021 Mar 01; 320(3):F475-F484. PubMed ID: 33491567 [Abstract] [Full Text] [Related]
7. [Urinary calcium oxalate supersaturation beyond nephrolithiasis. Relationship with tubulointerstitial damage]. Toblli JE, Angerosa M, Stella I, Ferder L, Inserra F. Medicina (B Aires); 2003 Mar 01; 63(2):97-104. PubMed ID: 12793076 [Abstract] [Full Text] [Related]
9. Pathophysiological correlates of two unique renal tubule lesions in rats with intestinal resection. Worcester E, Evan A, Bledsoe S, Lyon M, Chuang M, Orvieto M, Gerber G, Coe F. Am J Physiol Renal Physiol; 2006 Nov 01; 291(5):F1061-9. PubMed ID: 17028259 [Abstract] [Full Text] [Related]
10. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis. Marengo SR, Chen D, MacLennan GT, Resnick MI, Jacobs GH. J Urol; 2004 Mar 01; 171(3):1304-8. PubMed ID: 14767338 [Abstract] [Full Text] [Related]
11. Continuous infusion of oxalate by minipumps induces calcium oxalate nephrocalcinosis. Marengo SR, Chen DH, Evan AP, Sommer AJ, Stowe NT, Ferguson DG, Resnick MI, MacLennan GT. Urol Res; 2006 Jun 01; 34(3):200-10. PubMed ID: 16479391 [Abstract] [Full Text] [Related]
13. A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I. Worcester EM, Evan AP, Coe FL, Lingeman JE, Krambeck A, Sommers A, Phillips CL, Milliner D. Am J Physiol Renal Physiol; 2013 Dec 01; 305(11):F1574-84. PubMed ID: 24089413 [Abstract] [Full Text] [Related]
14. Calcium oxalate crystal deposition in the kidney: identification, causes and consequences. Geraghty R, Wood K, Sayer JA. Urolithiasis; 2020 Oct 01; 48(5):377-384. PubMed ID: 32719990 [Abstract] [Full Text] [Related]
15. Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. Wesson JA, Johnson RJ, Mazzali M, Beshensky AM, Stietz S, Giachelli C, Liaw L, Alpers CE, Couser WG, Kleinman JG, Hughes J. J Am Soc Nephrol; 2003 Jan 01; 14(1):139-47. PubMed ID: 12506146 [Abstract] [Full Text] [Related]
17. Oxalate and calcium oxalate crystals are injurious to renal epithelial cells: results of in vivo and in vitro studies. Thamilselvan S, Khan SR. J Nephrol; 1998 Jan 01; 11 Suppl 1():66-9. PubMed ID: 9604816 [Abstract] [Full Text] [Related]
18. Kidney models of calcium oxalate stone formation. Robertson WG. Nephron Physiol; 2004 Jan 01; 98(2):p21-30. PubMed ID: 15499211 [Abstract] [Full Text] [Related]